In trading on Tuesday, shares of Nektar Therapeutics (NKTR - Get Report) crossed below their 200 day moving average of $11.96, changing hands as low as $11.92 per share. Nektar Therapeutics shares are currently trading down about 2.7% on the day. The chart below shows the one year performance of NKTR shares, versus its 200 day moving average:Looking at the chart above, NKTR's low point in its 52 week range is $8.87 per share, with $15.34 as the 52 week high point — that compares with a last trade of $12.07. According to the ETF Finder at ETF Channel, NKTR makes up 4.74% of the First Trust NYSE Arca Biotechnology Index Fund ETF ( FBT) which is trading lower by about 1.6% on the day Tuesday.
More from Stocks
Retailer Destination Maternity Files for Chapter 11 Bankruptcy
The mall-based retailer, like many of its peers, has suffered from the explosion of online commerce.
Market Wrap: Muted Response to Trade Progress, Goldman Sachs Note on Buybacks
S&P 500 buybacks were down 18% in the second quarter according to a Goldman Sachs note.
How Investors Should Approach Positive Headlines Around U.S.-China Trade War
We're finally getting positive headlines around the U.S.-China trade war. Is it too soon to start celebrating?